lumbar radicular pain. Lumbosacral plexus disorders
Conditions
Interventions
Intervention 1: Control group: transforaminal hyaluronidase received triamcinolone 20 mg,ropivacaine 0/2% 3cc,hyaluronidase 1500 units. Intervention 2: Intervention
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Radicular lumbar pain for more than 6 months Disc protrusion One or two levels are involved No response to conservative therapy for 3 months Pain score more than 3
Exclusion criteria
Exclusion criteria: Patient,s discontent ASA more than 2 Spine deformity Vertebral listhesis ,grade 2 or more Lumbar spine surgery Anti coagulation therapy Drug and alcohol abuse Drug allergic reactions Local or systemic infection Pregnancy MRI contraindications Severe pulmonary disease Severe psychiatric disease Peripheral neuropathy Spine fracture
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale. Timepoint: 2 weeks-1 month- 2 months-3 months. Method of measurement: asking from patient.;Oswestry Disability Index. Timepoint: 2 weeks-1 month-2 months -3 months. Method of measurement: asking from patient.;Consumed- drugs. Timepoint: 2 weeks-1 month-2 months -3 months. Method of measurement: asking from patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahmoodreza Alebouyeh
Iran University of Medical Sciences
Outcome results
None listed